Gene Therapy Hits Its Goal in BCG-Unresponsive NMIBC

]]>(MedPage Today) -- WASHINGTON--An investigational interferon-based gene therapy led to complete responses in more than half of patients with non–muscle-invasive bladder cancer (NMIBC) unresponsive to bacillus Calmette-Guerin (BCG) therapy...